Related Funds
Fund Name | Location |
A-Five | Japan, Tokyo |
Amethis Finance | France, Ile-de-France, Paris |
Arkblu Capital | Indonesia, Jakarta, Jakarta Raya |
Bain Capital Credit | Boston, Massachusetts, United States |
Blue Shield of California | California, San Francisco, United States |
CIDCO | California, Morgan Hill, United States |
Emigrant Capital | New York, New York, United States |
Jiahesheng Maoyi | China, Fujian, Zhangpu |
Kunshan Zhouyuan Electronics | China, Jiangsu, Suzhou |
NetEase Capital | Beijing, Beijing, China |
Newton Fund | California, San Francisco, United States |
Qingke Huacheng Investment | China, Guangdong, Shenzhen |
Red Hook Capital | California, Sunnyvale, United States |
Season Two Ventures | Bengaluru, India, Karnataka |
Shenzhen Lianrun Oriental Equity Investment Fund Management | China, Guangdong, Shenzhen |
Spinnaker Ventures | California, San Francisco, United States |
The Ashforth Company | Connecticut, Stamford, United States |
TIAN JIAN | Beijing, Beijing, China |
Tokio Marine Nichido | Dubai, United Arab Emirates |
Zesheng Ziben | China, Guangdong, Tianjin |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Huateng Biotech | 23 Sep 2024 | Guangzhou, Guangdong, China | |||
Shineyo Medical | $15M | 12 Aug 2024 | Shanghai, Shanghai, China | ||
Sinchoo medical | 03 Jul 2024 | Guangzhou, Guangdong, China | |||
Sealien | 26 Jun 2024 | Guangzhou, Guangdong, China | |||
Neuexcell Therapeutics | $15M | 04 May 2023 | State College, Pennsylvania, United States | ||
Guanzhan | 15 Dec 2022 | Guangzhou, Guangdong, China | |||
Risong Technology | $27M | 22 Nov 2016 | China, Huangpu District | ||
Recomgen Biotech | $1M | 19 Apr 2016 | Guangzhou, Guangdong, China | ||
Recomgen Biotech | $463K | 24 Oct 2000 | Guangzhou, Guangdong, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Huateng Biotech | 23 Sep 2024 | Guangzhou, Guangdong, China | |||
Shineyo Medical | $15M | 12 Aug 2024 | Shanghai, Shanghai, China | ||
Sinchoo medical | 03 Jul 2024 | Guangzhou, Guangdong, China | |||
Sealien | 26 Jun 2024 | Guangzhou, Guangdong, China | |||
Neuexcell Therapeutics | $15M | 04 May 2023 | State College, Pennsylvania, United States | ||
Guanzhan | 15 Dec 2022 | Guangzhou, Guangdong, China | |||
Risong Technology | $27M | 22 Nov 2016 | China, Huangpu District | ||
Recomgen Biotech | $1M | 19 Apr 2016 | Guangzhou, Guangdong, China | ||
Recomgen Biotech | $463K | 24 Oct 2000 | Guangzhou, Guangdong, China |